Ascites fluid from a BALB/c mouse, injected with 11-4.1 hybridoma cells (15) (obtained from Dr. Inga Meichers, Stanford University, Palo Alto, Calif.) was the source of monoclonal antibody recognizing a public specificity common to H-2K k, H-2K p, H-2K q, and H-2K r. This antibody is also of the IgG2a class and was used at a 1:1,000 dilution.
The monoclonal antibody that detects a stage-specific embryonic surface antigen-1 (SSEA-1) expressed on early embryo and ECC has been described in detail (16) . The anti-SSEA-1 reagent used was serum from an ascites-bearing BALB/c mouse that had been injected intraperitoneally with 106 anti-SSEA-1 antibody-producing hybrid cells mixed with Freund's complete adjuvant. The anti-SSEA-1 reagent was used at a dilution of 1:32,000 (~75% of the maximal binding on F9 BrdU 7C12 cells).
Preparation of Cells for Immunoassays.
Tissue culture cells were harvested, counted, and suspended in 0.01 M Hepes-buffered (Sigma Chemical Co., St. Louis, Mo.) Eagle's minimal essential medium (MEM) that contained 10% FBS. Splenic lymphocytes were obtained from freshly dissected and teased spleens after lysis of erythrocytes and centrifugation through a layer of FicolI-Hypaque (1.077 g/ml) (LymphoPrep, Nyegaard and Co., Oslo, Norway). Linbro round-bottom microtiter plates (IS-RB-96, Linbro Chemical Co.) were used for all incubations of target cells with antisera.
Immunoassays. The RIA and the preparation of 12SI-rabbit anti-mouse IgM and IgG are described elsewhere (17) . Results are reported as the average counts per minute from triplicate samples minus the average counts per minute bound to cells incubated with a corresponding dilution of control myeloma-induced ascites fluid.
Absorption of conventional H°2 antisera was performed by incubating increasing numbers of hybrid or control cells (0.5 × 106, 2 × 106, and 8 × 106) in 60 #1 of antiserum at a dilution sufficient to lyse 60-85% of target splenic lymphocytes. After incubation at 4°C for 60 min on a shaker, the cell suspensions were centrifuged and the su~ernates assayed. For cytotoxicity tests, 9 #1 of target cell suspension that contained 3 × 10 cells was added to the 50 #l of absorbed serum, incubated at 36°C for 30 min on a shaker, and washed once with PBS that contained 2.5% FBS. The target cell pellets were then resuspended in 50#1 of rabbit complement (diluted 1:10 with Hepes-MEM) and incubated for 30 min at 36°C on a shaker. The percentage of dead cells was determined by erythrosin B dye exclusion. C57BL/6Jband 129/J splenic lymphocytes or EL-4 cells were used as targets for anti-H-2K and -2D sera; AKR/J and C3H/HeJ splenic lymphocytes were used as targets for anti-H-2K k and -2D k sera; and BALB/ c ICR (Institute for Cancer Research, Fox Chase, Pa.) splenic lymphocytes for anti-H-2D d serum. Absorption of antisera was always performed with all three cell concentrations; however, for ease of comparison, data are sometimes presented as the percent reduction of cytotoxicity on target lymphocytes after absorption with 2 × 106 cells only.
Results
Two series of hybrid clones were investigated: PCC4 aza 1 fused with C3H spleen cells (the 477 series) and F9 BrdU 7C12 fused with BW 5147 (the 978 series). The 477 hybrids resemble ECC morphologically, and both ECC and five independent 477 hybrids bind antibody to the stem cell-specific surface marker SSEA-1 (Table I ). In addition, clones of the 477 hybrids do not express the H-2 antigens of the H-2 b or H-2 k haplotype. Fig. 1 a gives an example in which anti-H-2D k serum failed to be absorbed with increasing numbers of cells from 477-1 clones I, DD, and GG. Identical data were obtained with antisera specific for the H-2D b, -2K b, or -2K k molecules (Table II) .
If these clones were maintained without subcuhivation, but with medium change every 2nd d for 2-3 wk (aged cultures), differentiated cells appeared and became the dominant subpopulation in the cultures. Data from two representative experiments concerning expression of H-2 antigens on aged cultures are presented in Fig. 1 b and Table II . The D4 antiserum is included for control purposes. Cells from the aged 477-1 GG clone absorb the cytotoxic activity from the four H°2 sera specific for the H- It was possible that the presence of antibodies against Ia determinants in the two antisera directed against the H-2K specificities could alter the absorption results obtained. To exclude this possibility, we tested the anti-H-2K b serum after absorption both on H-2K b-and Ia-expressing C57BL/6J spleen lymphocytes, and on Ia-negative, H-2Kb-positive EL-4 cells. Activity of the absorbed antiserum was reduced to the same extent on both target cells. A monoclonal antibody to a public specificity present on the product of the H-2K k allele, and not of the H-2K b allele, was also used to (Table III) confirms the results obtained by absorption. The 477-1 GG aged clone reacts with this monoclonal reagent, whereas the two other aged clones do not. Hybrids of the 978 series (F9 BrdU × BW 5147) are morphologically different from each of the parental cells. These hybrids are large, substrate-attached fibroblastic cells and do not express either the SSEA-1 surface marker of the teratocarcinoma parent (Table I) or the Thy-l.1 marker present on BW 5147 cells (results not shown). In contrast to the 477-1 hybrid clones, H-2 antigens are expressed on each of the three hybrid clones tested. To control the H-2 assays, two SV40-transformed, substrateattached cell lines (K129SV and KC3HSV) derived from mice of the same H-2 haplotype as the parental cells of the hybrid were used, as well as AKR/J and 129/J lymphocytes and both parental cell lines (F9 BrdU 7C12 and BW 5147). Splenic lymphocytes absorb slightly more of the specific reactivity from specific test sera than the SV40-transformed control cell lines, whereas BW 5147 absorbs considerably less. (Fig. 2) . The same results were repeatedly obtained with different passages of these hybrid clones. Each of the original hybrid clones were subcloned, and the subclones were also repeatedly analyzed for H-2 expression. Results from a representative experiment are shown in Table IV . For comparative purposes results taken from Fig. 2 are also shown on this table. By comparing the calculated percent reduction of cytotoxicity (Table  IV) with the absorption curves (Fig. 2) one can see that, e.g., 20.2% reduction of cytotoxicity of the D-33 sera after absorption with clone 978-2-1 is not significant because four times more cells absorb the same amount of activity. This same analysis was used to interpret all of the data in Table IV ( Table III Fig. 2 . § Percent reduction of cytotoxicity of anti-H-2 serum after absorption with 2 X 106 cells is calculated as described in Table II in hybrids of stem cell morphology is regulated as in ECC and rule out cis control of H-2 expression. Moreover, because H-2 antigenic specificities of both parents appear after aging in culture, loss of the chromosomes that bear the structural genes for H-2 is impossible. In previous reports (3, 4) , the authors examined the expression of only one of the H-2 gene products from each parental cell (H-2K k and -2K b or H-2K k and -2D b, respectively) ~tnd did not mention whether the cultures contained mixed populations of differentiated and stem cells. Because we show that H-2K and -2D gene expression are independently controlled and dependent upon in vitro differentiation, our data and those previously reported are not necessarily at variance, though our conclusions differ.
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H-2 Expression on PCC4 × Spleen Hybrid and Control Cells Detected by
Cells
Absorption Analysis
The 978 hybrids (F9 X BW 5147) are morphologically different from ECC and the 477 hybrids. The 978 hybrid clones do not express the teratocarcinoma-specific antigenic determinant SSEA-1 nor the thymoma characteristic Thy-1.1 and they do express H-2. Both the in vitro characteristics of the 978 hybrids and the fact that tumors derived from injection of 978 hybrid cells are not teratocarcinoma (data not shown) contrast these hybrid clones with the 477 hybrids and ECC.
Analysis of H-2 expression in these two sets of hybrids suggests two levels of control. If the hybrid cells are indistinguishable from ECC, the H-2 molecules of both parents are not expressed. We feel that positive suppression by regulatory gene products of the teratocarcinoma parent is the most probable mechanism. A second level of control is also suggested for we find that the H-2K and -2D gene products of both parental cells can be independently expressed. Furthermore, if H-2 antigenic determinants are present on the hybrid cell surface, the H-2D gene products are always found and the H-2K genes may or may not be expressed. The absence of the H-2K gene product, consequently, can not be explained by the loss of the chromosomes that contain the structural genes for H-2 or fl2-microglobulin.
Any attempts to postulate a mechanism for the control of H-2 expression must include the concept that there is no simple on/off control of all of the H-2 genes. The parental cell of the 978 hybrids, BW 5147, is derived from an AKR thymoma. Both the H-2K k and -2D k gene products are only weakly expressed on BW 5147 and it may be that the differentiated expression of H-2K in the hybrid cells is the consequence of aberrant gene regulation in this parental cell line. However, the 477 hybrids show independent expression of the H-2D gene products, and some clones of the 978 hybrids do strongly express the H-2K antigenic determinants. Preferential extinction of the H-2K gene product may simply be peculiar to the H-2 k haplotype because differential H-2K and -2D gene expression has been primarily observed in this haplotype (20) . 2 We believe that this regulatory control is H-2K gene specific and not allele specific because the data from these hybrid cells imply joint control of the H-2K k and -2K b gene products. We can postulate mutations that affect the H-2K and not the H-2D genes. The H-2K locus appears to be hypermutable in vivo because most of the mutations that affect H-2 genes were found in the H-2K region (21) . Additionally, cell lines derived from AKR thymomas are reported to express products of the H-2D k gene, but not those of the H-2K k gene (20) . However, attempts to immunoselect for the absence of H-2 expression in cell cultures has resulted in isolation of cells that have lost either H-2K or H-2D expression (22) . We feel that mutation of the H-2K structural genes is highly unlikely because three of six independently derived clones from two different parental cell lines would have been affected by such a mutation. In two of these clones the H-2K products from both parental cells are affected. Moreover, two subclones of the 978-1-5 clone express the H-2K k gene product that is not present on the original clone. Another possible explanation for this differential expression is the loss of some of the chromosomes that contain the fl2-microglobulin structural genes; gene dosage would thus result in a limiting supply of /~2-microglobulin molecules. This mechanism would imply a preferential affinity of the H-2D gene products for fl2-microglobulin. The expression of the H-2K k specificities in the 978-1-5 subclone D8, once again could argue against this point.
A more likely explanation of our results is that regulatory genes exist with products specific for either the H-2K or the H-2D loci. These regulatory products would allow independent expression of the H-2K and -2D genes. We believe that the H-2D gene is expressed first during differentiation with subsequent activation of the H-2K gene. The H-2D-positive, H-2K-negative hybrids reported here would then represent intermediary steps in the differentiation process. This hypothesis is supported by the recent observation that populations of cells in the thymus are H-2K negative and H-2D positive, whereas peripheral T cells express products of both H-2K and -2D. 2 The hybrid clones and subclones described here, with their differing expression of the H-
